{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:56:16Z","timestamp":1793652976700,"version":"4.5.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.diabres.2025.112070","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T19:05:07Z","timestamp":1740596707000},"page":"112070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Transitioning between automated insulin delivery systems: A focus on personalisation"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-4969","authenticated-orcid":false,"given":"Pilar Isabel","family":"Beato-V\u00edbora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-3411","authenticated-orcid":false,"given":"Ana","family":"Chico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-1094","authenticated-orcid":false,"given":"Jesus","family":"Moreno-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9405-6333","authenticated-orcid":false,"given":"Sharona","family":"Azriel-Mira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-9397","authenticated-orcid":false,"given":"Lia","family":"Nattero-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-7358","authenticated-orcid":false,"given":"Rosario Vallejo","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-0988","authenticated-orcid":false,"given":"N\u00faria","family":"Alonso-Carril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-652X","authenticated-orcid":false,"given":"Olga","family":"Sim\u00f3-Servat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0164-4006","authenticated-orcid":false,"given":"Eva","family":"Aguilera-Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-8527","authenticated-orcid":false,"given":"Luz Mar\u00eda","family":"Reyes C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7286-6853","authenticated-orcid":false,"given":"Marisol Ruiz","family":"de Adana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-5046","authenticated-orcid":false,"given":"Marta","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4914-4131","authenticated-orcid":false,"given":"Rosa","family":"M\u00e1rquez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9743-9412","authenticated-orcid":false,"given":"Gonzalo","family":"D\u00edaz-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-122X","authenticated-orcid":false,"given":"Mar\u00eda Asunci\u00f3n","family":"Mart\u00ednez-Brocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5250-765X","authenticated-orcid":false,"given":"Khusama Alkadi","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena Alpa\u00f1\u00e9s","family":"Buesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5018-7104","authenticated-orcid":false,"given":"Mart\u00edn Cuesta","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diabres.2025.112070_b0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the MiniMed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"18","key":"10.1016\/j.diabres.2025.112070_b0010","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"iDCL trial research group. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.diabres.2025.112070_b0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"ADAPT study Group. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.diabres.2025.112070_b0020","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1111\/dom.15217","article-title":"ADAPT study Group. Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes","volume":"25","author":"Edd","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112070_b0025","doi-asserted-by":"crossref","unstructured":"Lee TTM, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, et al; AiDAPT Collaborative Group. Automated insulin delivery in women with pregnancy complicated by type 1 diabetes. N Engl J Med. 2023 Oct 26;389(17):1566-1578. doi: 10.1056\/NEJMoa2303911. Epub 2023 Oct PMID: 37796241.","DOI":"10.1056\/NEJMoa2303911"},{"key":"10.1016\/j.diabres.2025.112070_b0030","doi-asserted-by":"crossref","unstructured":"Alwan H, Wilinska ME, Ruan Y, Da Silva J, Hovorka R. Real-world evidence analysis of a hybrid closed-loop system. J Diabetes Sci Technol. 2023 Jul 8:19322968231185348. doi: 10.1177\/19322968231185348. Epub ahead of print. PMID: 37421250.","DOI":"10.1177\/19322968231185348"},{"issue":"S3","key":"10.1016\/j.diabres.2025.112070_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/dia.2023.0433","article-title":"Celebrating the data from 100,000 real-world users of the MiniMed\u2122 780G system in Europe, Middle East, and Africa collected over 3 years: from data to clinical evidence","volume":"26","author":"Choudhary","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2025.112070_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109784","article-title":"Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes","volume":"185","author":"Boscari","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.diabres.2025.112070_b0045","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2337\/dc23-0504","article-title":"Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomized controlled trials","volume":"46","author":"Zeng","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2025.112070_b0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13098-023-01144-4","article-title":"Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials","volume":"15","author":"Godoi","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.diabres.2025.112070_b0055","doi-asserted-by":"crossref","unstructured":"Fan W, Deng C, Xu R, Liu Z, Leslie RD, Zhou Z, et al. Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2024 Nov 13. doi: 10.4093\/dmj.2024.0130. Epub ahead of print. PMID: 39533812.","DOI":"10.4093\/dmj.2024.0130"},{"issue":"6","key":"10.1016\/j.diabres.2025.112070_b0060","doi-asserted-by":"crossref","first-page":"e3842","DOI":"10.1002\/dmrr.3842","article-title":"Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis","volume":"40","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"10.1016\/j.diabres.2025.112070_b0065","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1111\/dom.15718","article-title":"Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis","volume":"26","author":"Yang","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112070_b0070","article-title":"Efficacy of the hybrid closed loop insulin delivery system in children and adolescents with type 1 diabetes: a meta-analysis with trial sequential analysis","volume":"68","author":"Oliva Morgado Ferreira","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112070_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110052","article-title":"Long-term outcomes of an advanced hybrid closed-loop system: A focus on different subpopulations","volume":"191","author":"Beato-V\u00edbora","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2025.112070_b0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12916-024-03396-x","article-title":"Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes","volume":"22","author":"Ng","year":"2024","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.diabres.2025.112070_b0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2021.0097","article-title":"One year real-world use of the control-IQ advanced hybrid closed-loop technology","volume":"23","author":"Breton","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.diabres.2025.112070_b0090","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/dom.15008","article-title":"One-year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany","volume":"25","author":"Benhamou","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112070_b0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/dia.2023.0261","article-title":"Advanced hybrid closed-loop system achieves and maintains recommended time in range levels for up to 2 years: predictors of best efficacy","volume":"26","author":"Lepore","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"15","key":"10.1016\/j.diabres.2025.112070_b0100","article-title":"Glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system 2-year prospective, observational, two-center study","volume":"8","author":"Seget","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2025.112070_b0105","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Care in Diabetes-2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S146-S166. doi: 10.2337\/dc25-S007. PMID: 39651978; PMCID: PMC11635043.","DOI":"10.2337\/dc25-S007"},{"key":"10.1016\/j.diabres.2025.112070_b0110","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 14. Children and Adolescents: Standards of Care in Diabetes-2025. Diabetes Care. 2025 Jan 1;48(Supplement_1):S283-S305. doi: 10.2337\/dc25-S014. PMID: 39651980; PMCID: PMC11635046.","DOI":"10.2337\/dc25-S014"},{"key":"10.1016\/j.diabres.2025.112070_b0115","doi-asserted-by":"crossref","unstructured":"Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard ME, et al. ISPAD Clinical Practice Consensus Guidelines 2024: Diabetes Technologies: Insulin Delivery. Horm Res Paediatr. 2024 Dec 10:1-34. doi: 10.1159\/000543034. Epub ahead of print. PMID: 39657603.","DOI":"10.1159\/000543034"},{"issue":"2","key":"10.1016\/j.diabres.2025.112070_b0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/dc23-1355","article-title":"A multicenter prospective evaluation of the benefits of two advanced hybrid closed-loop systems in glucose control and patient-reported outcomes in a real-world setting","volume":"47","author":"Beato-V\u00edbora","year":"2024","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2025.112070_b0125","article-title":"A comparison of two hybrid closed-loop systems in italian children and adults with type 1 diabetes","volume":"18","author":"Bassi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.diabres.2025.112070_b0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/dom.15344","article-title":"Beneficial effects of automated insulin delivery over one-year follow-up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics","volume":"26","author":"Henry","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112070_b0135","doi-asserted-by":"crossref","unstructured":"Borella ND, Ferramosca A, Castagna G, Ippolito S, Ceresoli S, Taverna A, et al. Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybrid closed-loop systems. Acta Diabetol. 2024 Nov 22. doi: 10.1007\/s00592-024-02397-9. Epub ahead of print. PMID: 39576311.","DOI":"10.1007\/s00592-024-02397-9"},{"key":"10.1016\/j.diabres.2025.112070_b0140","doi-asserted-by":"crossref","unstructured":"Folk S, Zappe J, Wyne K, Dungan KM. Comparative effectiveness of hybrid closed-loop automated insulin delivery systems among patients with type 1 diabetes. J Diabetes Sci Technol. 2024 Apr 1:19322968241234948. doi: 10.1177\/19322968241234948. Epub ahead of print. PMID: 38557128; PMCID: PMC11571516.","DOI":"10.1177\/19322968241234948"},{"key":"10.1016\/j.diabres.2025.112070_b0145","doi-asserted-by":"crossref","unstructured":"Gargouri I, Charfi H, Belabed W, Outenah C, Pochat A, Touimer M, et al. Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control-IQ and MiniMed 780G according to patient characteristics. Diabetes Obes Metab. 2024 Dec 17. doi: 10.1111\/dom.16118. Epub ahead of print. PMID: 39690388.","DOI":"10.1111\/dom.16118"},{"issue":"14","key":"10.1016\/j.diabres.2025.112070_b0150","article-title":"Are all HCL systems the same? Long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study","volume":"16","author":"Santova","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.diabres.2025.112070_b0155","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00592-022-01886-z","article-title":"Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study","volume":"59","author":"Schiaffini","year":"2022","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112070_b0160","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.diabres.2025.112070_b0165","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.2337\/dci22-0018","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. a consensus report of the joint diabetes technology working group of the european association for the study of diabetes and the american diabetes association","volume":"45","author":"Sherr","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112070_b0170","doi-asserted-by":"crossref","unstructured":"Gallen G, Rosso A, Alonso-Carril N, Arbeli S, Bahon V, Brown V, et al. Expert panel opinion on the optimal educational pathway for diabetes educators for training people with type 1 diabetes on the MiniMed\u2122 780G system: a Delphi consensus. Acta Diabetol. 2024 Oct 29. doi: 10.1007\/s00592-024-02388-w. Epub ahead of print. Erratum in: Acta Diabetol. 2024 Dec 26. doi: 10.1007\/s00592-024-02435-6. PMID: 39470803.","DOI":"10.1007\/s00592-024-02435-6"},{"issue":"8","key":"10.1016\/j.diabres.2025.112070_b0175","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care."},{"key":"10.1016\/j.diabres.2025.112070_b0180","doi-asserted-by":"crossref","unstructured":"Madrid-Valero JJ, Scott EM, Boughton CK, Allen JM, Ware J, Wilinska ME, et al. Closed-loop therapy and sleep in young people newly diagnosed with T1D and their parents. J Diabetes Sci Technol. 2024 Oct 14:19322968241286816. doi: 10.1177\/19322968241286816. Epub ahead of print. PMID: 39397750; PMCID: PMC11571613.","DOI":"10.1177\/19322968241286816"},{"key":"10.1016\/j.diabres.2025.112070_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108986","article-title":"Amelioration of user experiences and glycaemic outcomes with an advanced hybrid closed loop system in a real-world clinical setting","volume":"178","author":"Beato-V\u00edbora","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.diabres.2025.112070_b0190","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/dom.15462","article-title":"The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes","volume":"26","author":"Reznik","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.diabres.2025.112070_b0195","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15099","article-title":"A systematic review on the impact of commercially available hybrid closed loop systems on psychological outcomes in youths with type 1 diabetes and their parents","volume":"40","author":"Franceschi","year":"2023","journal-title":"Diabet Med."},{"key":"10.1016\/j.diabres.2025.112070_b0200","doi-asserted-by":"crossref","unstructured":"Lebbar M, Bonhoure A, Rabasa-Lhoret R, Wu Z. Switching from open-source to commercial advanced automated insulin delivery system: glucose management and patient perspective in an adult living with type 1 diabetes. Can J Diabetes. 2024 Dec 24:S1499-2671(24)00414-3. doi: 10.1016\/j.jcjd.2024.12.004. Epub ahead of print. PMID: 39725345.","DOI":"10.1016\/j.jcjd.2024.12.004"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:26:18Z","timestamp":1763706378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"alternative-id":["S0168822725000841"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112070","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transitioning between automated insulin delivery systems: A focus on personalisation","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112070"}}